Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis
Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis
Not yet recruiting · NCT07650942 · Registry updated 2026-06-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 3 | 2026-06-16 | NCT07650942 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ganzhou Hemay Pharmaceutical Co., Ltd | 8 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital,Sun Yat-sen University | Guangzhou | China | 2 |
| The Sixth Affiliated Hospital,Sun Yat-sen University | Guangzhou | China | 2 |